Search Results 1601-1610 of 19485 for Myocardium

  1. Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer - Mayo Clinic

    History of myocardial infarction ≤ 6 months prior to pre-registration, or congestive heart failure requiring use of ongoing maintenance therapy for life ...

  2. Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure - Mayo Clinic

    * Acute myocardial infarction Type 1 within 30 days of enrollment, or planned coronary revascularization in the next 30 days; * Stroke within 30 days of ...

  3. Gurpreet S. Sandhu, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Myocardial biopsy; Pulmonary angiogram; Pulmonary artery pressure sensor implantation; Pulmonary vein stenting; Rotational atherectomy; Transcatheter aortic ...

  4. Study Of 225Ac-ABD147 To Establish Optimal Dose In Patients With SCLC And LCNEC Of The Lung That Previously Received Platinum-based Chemotherapy - Mayo Clinic

    * Has a medical history of myocardial infarction or unstable angina within 6 months before C1D1. * Has clinically significant cardiac disease not controlled ...

  5. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism - Mayo Clinic

    Chronic or severe cardiac disease within 26 weeks prior to Visit 1 including but not limited to congestive heart failure, myocardial infarction, QTcF >430 ...

  6. UBX1325 for Treatment of Neovascular ARMD - Mayo Clinic

    ... myocardial infarction within the last 6 months, or concomitant therapy. Eligibility last updated 9/3/21. Questions regarding updates should be directed to ...

  7. Comparison of Acute Toxicities Between Patients Treated With Protons or Intensity Modulated Radiation Therapy After Surgery for the Treatment of Endometrial or Cervical Cancer - Mayo Clinic

    - Transmural myocardial infarction within the last 6 months - Acute bacterial or fungal infection requiring intravenous antibiotics at the time of ...

  8. The ENCIRCLE Trial - Mayo Clinic

    Myocardial infarction within 30 days of the procedure. Clinically significant untreated coronary artery disease requiring revascularization. Any ...

  9. A Study of Pembrolizumab and Ruxolitinib Phosphate for Treating Patients with Metastatic Stage IV Triple Negative Breast Cancer - Mayo Clinic

    Acute myocardial infarction prior to registration;; New York Heart Association classification IV cardiovascular disease or symptomatic class III disease ...

  10. A Study to Evaluate the Effectiveness and Safety of PCS499 in Treating Ulcerations in Patients who have Necrobiosis Lipoidica - Mayo Clinic

    Clinically significant cardiac disease including but not limited to unstable angina, acute myocardial infarction within 6 months of Baseline, and arrhythmia ...